Report Detail
Global On-body Injectors Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
- RnM4558403 |
- 15 October, 2023 |
- Global |
- 105 Pages |
- GIR (Global Info Research) |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global On-body Injectors market size was valued at USD 148.2 million in 2022 and is forecast to a readjusted size of USD 378.9 million by 2029 with a CAGR of 14.4% during review period.
On-body injectors, also known as on-body delivery systems (OBDS), are medical devices designed to deliver a controlled dose of medication or therapeutic substances subcutaneously (under the skin) over a specified period. These devices are typically worn on the body and are used to administer various treatments, including medications, hormones, and biologics. On-body injectors offer several advantages, including increased patient convenience, improved medication adherence, and the ability to deliver complex therapies.
The scope of this report is non-insulin On-body injectors.
In the global market, On-body Injectors is dominated by core players such as AWest Pharmaceutical Services, Insulet, Gerresheimer, ect. The top three players within this industry account for about 80% of the market share. North America, Europe, and Asia-Pacific are the major manufacturing regions for this product, and they all hold about 15% of the global market share. The product can be categorised on the basis of product type into electronic syringes and mechanical syringes. The product is widely used in the treatment of oncology immunology, cardiovascular diseases, neurological disorders, and other diseases.
The Global Info Research report includes an overview of the development of the On-body Injectors industry chain, the market status of Immuno-oncology (Electronic Injectors, Mechanical Injectors), Cardiovascular Diseases (Electronic Injectors, Mechanical Injectors), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of On-body Injectors.
Regionally, the report analyzes the On-body Injectors markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global On-body Injectors market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the On-body Injectors market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the On-body Injectors industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Electronic Injectors, Mechanical Injectors).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the On-body Injectors market.
Regional Analysis: The report involves examining the On-body Injectors market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the On-body Injectors market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to On-body Injectors:
Company Analysis: Report covers individual On-body Injectors manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards On-body Injectors This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Immuno-oncology, Cardiovascular Diseases).
Technology Analysis: Report covers specific technologies relevant to On-body Injectors. It assesses the current state, advancements, and potential future developments in On-body Injectors areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the On-body Injectors market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
On-body Injectors market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Electronic Injectors
Mechanical Injectors
Market segment by Application
Immuno-oncology
Cardiovascular Diseases
Neurological Diseases
Others
Major players covered
West Pharmaceutical Services
Insulet
Gerresheimer
United Therapeutics
CC Bio
BD
Ypsomed
Enable Injections
Nemera
Stevanato Group
Sonceboz
Lohmann Therapie-Systeme
Elcam Drug Delivery Devices (E3D)
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe On-body Injectors product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of On-body Injectors, with price, sales, revenue and global market share of On-body Injectors from 2018 to 2023.
Chapter 3, the On-body Injectors competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the On-body Injectors breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and On-body Injectors market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of On-body Injectors.
Chapter 14 and 15, to describe On-body Injectors sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of On-body Injectors
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global On-body Injectors Consumption Value by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Electronic Injectors
- 1.3.3 Mechanical Injectors
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global On-body Injectors Consumption Value by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Immuno-oncology
- 1.4.3 Cardiovascular Diseases
- 1.4.4 Neurological Diseases
- 1.4.5 Others
- 1.5 Global On-body Injectors Market Size & Forecast
- 1.5.1 Global On-body Injectors Consumption Value (2018 & 2022 & 2029)
- 1.5.2 Global On-body Injectors Sales Quantity (2018-2029)
- 1.5.3 Global On-body Injectors Average Price (2018-2029)
2 Manufacturers Profiles
- 2.1 West Pharmaceutical Services
- 2.1.1 West Pharmaceutical Services Details
- 2.1.2 West Pharmaceutical Services Major Business
- 2.1.3 West Pharmaceutical Services On-body Injectors Product and Services
- 2.1.4 West Pharmaceutical Services On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 West Pharmaceutical Services Recent Developments/Updates
- 2.2 Insulet
- 2.2.1 Insulet Details
- 2.2.2 Insulet Major Business
- 2.2.3 Insulet On-body Injectors Product and Services
- 2.2.4 Insulet On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Insulet Recent Developments/Updates
- 2.3 Gerresheimer
- 2.3.1 Gerresheimer Details
- 2.3.2 Gerresheimer Major Business
- 2.3.3 Gerresheimer On-body Injectors Product and Services
- 2.3.4 Gerresheimer On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Gerresheimer Recent Developments/Updates
- 2.4 United Therapeutics
- 2.4.1 United Therapeutics Details
- 2.4.2 United Therapeutics Major Business
- 2.4.3 United Therapeutics On-body Injectors Product and Services
- 2.4.4 United Therapeutics On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 United Therapeutics Recent Developments/Updates
- 2.5 CC Bio
- 2.5.1 CC Bio Details
- 2.5.2 CC Bio Major Business
- 2.5.3 CC Bio On-body Injectors Product and Services
- 2.5.4 CC Bio On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 CC Bio Recent Developments/Updates
- 2.6 BD
- 2.6.1 BD Details
- 2.6.2 BD Major Business
- 2.6.3 BD On-body Injectors Product and Services
- 2.6.4 BD On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 BD Recent Developments/Updates
- 2.7 Ypsomed
- 2.7.1 Ypsomed Details
- 2.7.2 Ypsomed Major Business
- 2.7.3 Ypsomed On-body Injectors Product and Services
- 2.7.4 Ypsomed On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Ypsomed Recent Developments/Updates
- 2.8 Enable Injections
- 2.8.1 Enable Injections Details
- 2.8.2 Enable Injections Major Business
- 2.8.3 Enable Injections On-body Injectors Product and Services
- 2.8.4 Enable Injections On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 Enable Injections Recent Developments/Updates
- 2.9 Nemera
- 2.9.1 Nemera Details
- 2.9.2 Nemera Major Business
- 2.9.3 Nemera On-body Injectors Product and Services
- 2.9.4 Nemera On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 Nemera Recent Developments/Updates
- 2.10 Stevanato Group
- 2.10.1 Stevanato Group Details
- 2.10.2 Stevanato Group Major Business
- 2.10.3 Stevanato Group On-body Injectors Product and Services
- 2.10.4 Stevanato Group On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.10.5 Stevanato Group Recent Developments/Updates
- 2.11 Sonceboz
- 2.11.1 Sonceboz Details
- 2.11.2 Sonceboz Major Business
- 2.11.3 Sonceboz On-body Injectors Product and Services
- 2.11.4 Sonceboz On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.11.5 Sonceboz Recent Developments/Updates
- 2.12 Lohmann Therapie-Systeme
- 2.12.1 Lohmann Therapie-Systeme Details
- 2.12.2 Lohmann Therapie-Systeme Major Business
- 2.12.3 Lohmann Therapie-Systeme On-body Injectors Product and Services
- 2.12.4 Lohmann Therapie-Systeme On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.12.5 Lohmann Therapie-Systeme Recent Developments/Updates
- 2.13 Elcam Drug Delivery Devices (E3D)
- 2.13.1 Elcam Drug Delivery Devices (E3D) Details
- 2.13.2 Elcam Drug Delivery Devices (E3D) Major Business
- 2.13.3 Elcam Drug Delivery Devices (E3D) On-body Injectors Product and Services
- 2.13.4 Elcam Drug Delivery Devices (E3D) On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.13.5 Elcam Drug Delivery Devices (E3D) Recent Developments/Updates
3 Competitive Environment: On-body Injectors by Manufacturer
- 3.1 Global On-body Injectors Sales Quantity by Manufacturer (2018-2023)
- 3.2 Global On-body Injectors Revenue by Manufacturer (2018-2023)
- 3.3 Global On-body Injectors Average Price by Manufacturer (2018-2023)
- 3.4 Market Share Analysis (2022)
- 3.4.1 Producer Shipments of On-body Injectors by Manufacturer Revenue ($MM) and Market Share (%): 2022
- 3.4.2 Top 3 On-body Injectors Manufacturer Market Share in 2022
- 3.4.2 Top 6 On-body Injectors Manufacturer Market Share in 2022
- 3.5 On-body Injectors Market: Overall Company Footprint Analysis
- 3.5.1 On-body Injectors Market: Region Footprint
- 3.5.2 On-body Injectors Market: Company Product Type Footprint
- 3.5.3 On-body Injectors Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global On-body Injectors Market Size by Region
- 4.1.1 Global On-body Injectors Sales Quantity by Region (2018-2029)
- 4.1.2 Global On-body Injectors Consumption Value by Region (2018-2029)
- 4.1.3 Global On-body Injectors Average Price by Region (2018-2029)
- 4.2 North America On-body Injectors Consumption Value (2018-2029)
- 4.3 Europe On-body Injectors Consumption Value (2018-2029)
- 4.4 Asia-Pacific On-body Injectors Consumption Value (2018-2029)
- 4.5 South America On-body Injectors Consumption Value (2018-2029)
- 4.6 Middle East and Africa On-body Injectors Consumption Value (2018-2029)
5 Market Segment by Type
- 5.1 Global On-body Injectors Sales Quantity by Type (2018-2029)
- 5.2 Global On-body Injectors Consumption Value by Type (2018-2029)
- 5.3 Global On-body Injectors Average Price by Type (2018-2029)
6 Market Segment by Application
- 6.1 Global On-body Injectors Sales Quantity by Application (2018-2029)
- 6.2 Global On-body Injectors Consumption Value by Application (2018-2029)
- 6.3 Global On-body Injectors Average Price by Application (2018-2029)
7 North America
- 7.1 North America On-body Injectors Sales Quantity by Type (2018-2029)
- 7.2 North America On-body Injectors Sales Quantity by Application (2018-2029)
- 7.3 North America On-body Injectors Market Size by Country
- 7.3.1 North America On-body Injectors Sales Quantity by Country (2018-2029)
- 7.3.2 North America On-body Injectors Consumption Value by Country (2018-2029)
- 7.3.3 United States Market Size and Forecast (2018-2029)
- 7.3.4 Canada Market Size and Forecast (2018-2029)
- 7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
- 8.1 Europe On-body Injectors Sales Quantity by Type (2018-2029)
- 8.2 Europe On-body Injectors Sales Quantity by Application (2018-2029)
- 8.3 Europe On-body Injectors Market Size by Country
- 8.3.1 Europe On-body Injectors Sales Quantity by Country (2018-2029)
- 8.3.2 Europe On-body Injectors Consumption Value by Country (2018-2029)
- 8.3.3 Germany Market Size and Forecast (2018-2029)
- 8.3.4 France Market Size and Forecast (2018-2029)
- 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
- 8.3.6 Russia Market Size and Forecast (2018-2029)
- 8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
- 9.1 Asia-Pacific On-body Injectors Sales Quantity by Type (2018-2029)
- 9.2 Asia-Pacific On-body Injectors Sales Quantity by Application (2018-2029)
- 9.3 Asia-Pacific On-body Injectors Market Size by Region
- 9.3.1 Asia-Pacific On-body Injectors Sales Quantity by Region (2018-2029)
- 9.3.2 Asia-Pacific On-body Injectors Consumption Value by Region (2018-2029)
- 9.3.3 China Market Size and Forecast (2018-2029)
- 9.3.4 Japan Market Size and Forecast (2018-2029)
- 9.3.5 Korea Market Size and Forecast (2018-2029)
- 9.3.6 India Market Size and Forecast (2018-2029)
- 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
- 9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
- 10.1 South America On-body Injectors Sales Quantity by Type (2018-2029)
- 10.2 South America On-body Injectors Sales Quantity by Application (2018-2029)
- 10.3 South America On-body Injectors Market Size by Country
- 10.3.1 South America On-body Injectors Sales Quantity by Country (2018-2029)
- 10.3.2 South America On-body Injectors Consumption Value by Country (2018-2029)
- 10.3.3 Brazil Market Size and Forecast (2018-2029)
- 10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
- 11.1 Middle East & Africa On-body Injectors Sales Quantity by Type (2018-2029)
- 11.2 Middle East & Africa On-body Injectors Sales Quantity by Application (2018-2029)
- 11.3 Middle East & Africa On-body Injectors Market Size by Country
- 11.3.1 Middle East & Africa On-body Injectors Sales Quantity by Country (2018-2029)
- 11.3.2 Middle East & Africa On-body Injectors Consumption Value by Country (2018-2029)
- 11.3.3 Turkey Market Size and Forecast (2018-2029)
- 11.3.4 Egypt Market Size and Forecast (2018-2029)
- 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
- 11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
- 12.1 On-body Injectors Market Drivers
- 12.2 On-body Injectors Market Restraints
- 12.3 On-body Injectors Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of On-body Injectors and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of On-body Injectors
- 13.3 On-body Injectors Production Process
- 13.4 On-body Injectors Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 On-body Injectors Typical Distributors
- 14.3 On-body Injectors Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on On-body Injectors. Industry analysis & Market Report on On-body Injectors is a syndicated market report, published as Global On-body Injectors Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of On-body Injectors market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
